Finnegan is a Supporting sponsor of the sixth annual American Conference Institute Biosimilars Congress. Finnegan partner Bill Raich will participate in the panel discussion “The Next Battle Ground: Strategies for Obtaining or Challenging Preliminary Injunctions” and Jonathan Davies will join the panel discussion “Obtaining Adequate Patent Protection While Operating in an “Anti-Patent” Climate: Factoring Key Cases into Your Biosimilars Patent Strategy.” The program will take place at the Affinia Manhattan in New York, New York. For more information, or to register, please see ACI’s website.
